{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:36:03Z","timestamp":1793853363020,"version":"4.6.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG046171, RF1AG051550, RF1AG057452, R01AG059093, RF1AG058942, U01AG061359, U19AG063744"],"award-info":[{"award-number":["R01AG046171, RF1AG051550, RF1AG057452, R01AG059093, RF1AG058942, U01AG061359, U19AG063744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["#DAOU16AMPA"],"award-info":[{"award-number":["#DAOU16AMPA"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-024-00682-w","type":"journal-article","created":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:10:47Z","timestamp":1736363447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer\u2019s disease in humans"],"prefix":"10.1038","volume":"5","author":[{"given":"Bryan J.","family":"Neth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6170-2207","authenticated-orcid":false,"given":"Kevin","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6050-1259","authenticated-orcid":false,"given":"Corey","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Mellett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2521-078X","authenticated-orcid":false,"given":"Thy","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Blach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Schimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4078-0166","authenticated-orcid":false,"given":"Thomas C.","family":"Register","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1890-4193","authenticated-orcid":false,"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-0086","authenticated-orcid":false,"given":"Richa","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9691-3741","authenticated-orcid":false,"given":"Annalise","family":"Schweickart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Hazel","family":"Dilmore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9334-1258","authenticated-orcid":false,"given":"Cameron","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-0923","authenticated-orcid":false,"given":"Matthias","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4734-3791","authenticated-orcid":false,"given":"Jan","family":"Krumsiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8615-2413","authenticated-orcid":false,"given":"Xianlin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter C.","family":"Dorrestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0975-9019","authenticated-orcid":false,"given":"Rob","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2593-4665","authenticated-orcid":false,"given":"Peter J.","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Craft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-5732","authenticated-orcid":false,"given":"Rima","family":"Kaddurah-Daouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"682_CR1","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/alz.12638","volume":"18","author":"J Gaugler","year":"2022","unstructured":"Gaugler, J. et al. Alzheimer\u2019s disease facts and figures. ALZHEIMERS DEMENTIA 18, 700\u2013789 (2022).","journal-title":"ALZHEIMERS DEMENTIA"},{"key":"682_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s13311-022-01201-2","volume":"19","author":"TE Golde","year":"2022","unstructured":"Golde, T. E. Disease-Modifying Therapies for Alzheimer\u2019s Disease: More Questions than Answers. Neurotherapeutics 19, 209\u2013227 (2022).","journal-title":"Neurotherapeutics"},{"key":"682_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/d41586-021-01546-2","volume":"594","author":"A Mullard","year":"2021","unstructured":"Mullard, A. Landmark Alzheimer\u2019s drug approval confounds research community. Nature 594, 309\u2013310 (2021).","journal-title":"Nature"},{"key":"682_CR4","unstructured":"Couzin-Frankel J. FDA approves new antibody to slow Alzheimer\u2019s disease, even as safety concerns linger. In. Science (2023)."},{"key":"682_CR5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","volume":"80","author":"JrCR Jack","year":"2013","unstructured":"Jack, Jr. C. R. & Holtzman, D. M. Biomarker modeling of Alzheimer\u2019s disease. Neuron 80, 1347\u20131358 (2013).","journal-title":"Neuron"},{"key":"682_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.14283\/jpad.2021.15","volume":"8","author":"XX Zhang","year":"2021","unstructured":"Zhang, X. X. et al. The Epidemiology of Alzheimer\u2019s Disease Modifiable Risk Factors and Prevention. J. Prev. Alzheimers Dis. 8, 313\u2013321 (2021).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"682_CR7","unstructured":"Wilder R. M. The effects of ketonemia on the course of epilepsy. Paper presented at: Mayo Clin Proc (1921)."},{"key":"682_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1528-1167.2008.01821.x","volume":"49","author":"JW Wheless","year":"2008","unstructured":"Wheless, J. W. History of the ketogenic diet. Epilepsia 49, 3\u20135 (2008).","journal-title":"Epilepsia"},{"key":"682_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1542\/peds.2006-2447","volume":"119","author":"JM Freeman","year":"2007","unstructured":"Freeman, J. M., Kossoff, E. H. & Hartman, A. L. The ketogenic diet: one decade later. Pediatrics 119, 535\u2013543 (2007).","journal-title":"Pediatrics"},{"key":"682_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev.pathol.4.110807.092314","volume":"5","author":"DC Wallace","year":"2010","unstructured":"Wallace, D. C., Fan, W. & Procaccio, V. Mitochondrial energetics and therapeutics. Annu Rev. Pathol. 5, 297\u2013348 (2010).","journal-title":"Annu Rev. Pathol."},{"key":"682_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.nurt.2009.01.005","volume":"6","author":"EH Kossoff","year":"2009","unstructured":"Kossoff, E. H. & Rho, J. M. Ketogenic diets: evidence for short- and long-term efficacy. Neurotherapeutics 6, 406\u2013414 (2009).","journal-title":"Neurotherapeutics"},{"key":"682_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.yebeh.2013.09.032","volume":"29","author":"EH Kossoff","year":"2013","unstructured":"Kossoff, E. H., Cervenka, M. C., Henry, B. J., Haney, C. A. & Turner, Z. A decade of the modified Atkins diet (2003\u20132013): Results, insights, and future directions. Epilepsy Behav. 29, 437\u2013442 (2013).","journal-title":"Epilepsy Behav."},{"key":"682_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1528-1167.2008.01831.x","volume":"49","author":"EH Kossoff","year":"2008","unstructured":"Kossoff, E. H. & Dorward, J. L. The modified Atkins diet. Epilepsia 49, 37\u201341 (2008).","journal-title":"Epilepsia"},{"key":"682_CR14","doi-asserted-by":"publisher","first-page":"e1002482","DOI":"10.1371\/journal.pmed.1002482","volume":"15","author":"VR Varma","year":"2018","unstructured":"Varma, V. R. et al. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. PLoS Med 15, e1002482 (2018).","journal-title":"PLoS Med"},{"key":"682_CR15","doi-asserted-by":"publisher","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","volume":"8","author":"E Trushina","year":"2013","unstructured":"Trushina, E., Dutta, T., Persson, X. M., Mielke, M. M. & Petersen, R. C. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics. PLoS One 8, e63644 (2013).","journal-title":"PLoS One"},{"key":"682_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","volume":"7","author":"R Kaddurah-Daouk","year":"2011","unstructured":"Kaddurah-Daouk, R. et al. Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease. Alzheimers Dement 7, 309\u2013317 (2011).","journal-title":"Alzheimers Dement"},{"key":"682_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/2051-5960-1-28","volume":"1","author":"AA Motsinger-Reif","year":"2013","unstructured":"Motsinger-Reif, A. A. et al. Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer\u2019s disease from normal cognitive aging. Acta Neuropathol. Commun. 1, 28 (2013).","journal-title":"Acta Neuropathol. Commun."},{"key":"682_CR18","doi-asserted-by":"publisher","first-page":"e21643","DOI":"10.1371\/journal.pone.0021643","volume":"6","author":"X Han","year":"2011","unstructured":"Han, X. et al. Metabolomics in early Alzheimer\u2019s disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One 6, e21643 (2011).","journal-title":"PLoS One"},{"key":"682_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100138","volume":"1","author":"P Baloni","year":"2020","unstructured":"Baloni, P. et al. Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer\u2019s Disease. Cell Rep. Med 1, 100138 (2020).","journal-title":"Cell Rep. Med"},{"key":"682_CR20","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.dadm.2019.07.002","volume":"11","author":"DK Barupal","year":"2019","unstructured":"Barupal, D. K. et al. Sets of coregulated serum lipids are associated with Alzheimer\u2019s disease pathophysiology. Alzheimers Dement (Amst.). 11, 619\u2013627 (2019).","journal-title":"Alzheimers Dement (Amst.)."},{"key":"682_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.263","volume":"5","author":"DK Barupal","year":"2018","unstructured":"Barupal, D. K. et al. Generation and quality control of lipidomics data for the alzheimer\u2019s disease neuroimaging initiative cohort. Sci. Data 5, 180263 (2018).","journal-title":"Sci. Data"},{"key":"682_CR22","unstructured":"Batra R., et al. The landscape of metabolic brain alterations in Alzheimer\u2019s disease. Alzheimers Dement. 2022."},{"key":"682_CR23","doi-asserted-by":"publisher","first-page":"e2088","DOI":"10.1212\/WNL.0000000000009436","volume":"94","author":"MM Bernath","year":"2020","unstructured":"Bernath, M. M. et al. Serum triglycerides in Alzheimer disease: Relation to neuroimaging and CSF biomarkers. Neurology 94, e2088\u2013e2098 (2020).","journal-title":"Neurology"},{"key":"682_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/alz.12675","volume":"19","author":"R Chang","year":"2023","unstructured":"Chang, R. et al. Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer\u2019s disease. Alzheimers Dement 19, 518\u2013531 (2023).","journal-title":"Alzheimers Dement"},{"key":"682_CR25","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1002\/alz.12468","volume":"18","author":"E Horgusluoglu","year":"2022","unstructured":"Horgusluoglu, E. et al. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer\u2019s disease. Alzheimers Dement 18, 1260\u20131278 (2022).","journal-title":"Alzheimers Dement"},{"key":"682_CR26","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/alz.12110","volume":"16","author":"MA Kling","year":"2020","unstructured":"Kling, M. A. et al. Circulating ethanolamine plasmalogen indices in Alzheimer\u2019s disease: Relation to diagnosis, cognition, and CSF tau. Alzheimers Dement 16, 1234\u20131247 (2020).","journal-title":"Alzheimers Dement"},{"key":"682_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab139","volume":"3","author":"K Nho","year":"2021","unstructured":"Nho, K. et al. Serum metabolites associated with brain amyloid beta deposition, cognition and dementia progression. Brain Commun. 3, fcab139 (2021).","journal-title":"Brain Commun."},{"key":"682_CR28","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","volume":"15","author":"K Nho","year":"2019","unstructured":"Nho, K. et al. Altered bile acid profile in mild cognitive impairment and Alzheimer\u2019s disease: Relationship to neuroimaging and CSF biomarkers. Alzheimers Dement 15, 232\u2013244 (2019).","journal-title":"Alzheimers Dement"},{"key":"682_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","volume":"13","author":"JB Toledo","year":"2017","unstructured":"Toledo, J. B. et al. Metabolic network failures in Alzheimer\u2019s disease: a biochemical road map. Alzheimer\u2019s. Dement. 13, 965\u2013984 (2017).","journal-title":"Alzheimer\u2019s. Dement."},{"key":"682_CR30","unstructured":"White D. The phospholipid composition of mammalian tissues. Form Function of phospholipids. 441-482 (1973)."},{"key":"682_CR31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1046\/j.1471-4159.1994.62031039.x","volume":"62","author":"L Svennerholm","year":"1994","unstructured":"Svennerholm, L. & Gottfries, C. G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem 62, 1039\u20131047 (1994).","journal-title":"J. Neurochem"},{"key":"682_CR32","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.biochi.2009.03.004","volume":"91","author":"S Florent-B\u00e9chard","year":"2009","unstructured":"Florent-B\u00e9chard, S. et al. The essential role of lipids in Alzheimer\u2019s disease. Biochimie 91, 804\u2013809 (2009).","journal-title":"Biochimie"},{"key":"682_CR33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nrd1776","volume":"4","author":"MR Wenk","year":"2005","unstructured":"Wenk, M. R. The emerging field of lipidomics. Nat. Rev. Drug Discov. 4, 594\u2013610 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"682_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19473-7","volume":"11","author":"K Huynh","year":"2020","unstructured":"Huynh, K. et al. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer\u2019s disease. Nat. Commun. 11, 5698 (2020).","journal-title":"Nat. Commun."},{"key":"682_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/1567205052772786","volume":"2","author":"X Han","year":"2005","unstructured":"Han, X. Lipid alterations in the earliest clinically recognizable stage of Alzheimer\u2019s disease: implication of the role of lipids in the pathogenesis of Alzheimer\u2019s disease. Curr. Alzheimer Res. 2, 65\u201377 (2005).","journal-title":"Curr. Alzheimer Res."},{"key":"682_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1471-4159.2007.04715.x","volume":"103","author":"T Hartmann","year":"2007","unstructured":"Hartmann, T., Kuchenbecker, J. & Grimm, M. O. Alzheimer\u2019s disease: the lipid connection. J. Neurochem. 103, 159\u2013170 (2007).","journal-title":"J. Neurochem."},{"key":"682_CR37","first-page":"1006","volume":"1851","author":"M Aureli","year":"2015","unstructured":"Aureli, M., Grassi, S., Prioni, S., Sonnino, S. & Prinetti, A. Lipid membrane domains in the brain. Biochim. et. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids 1851, 1006\u20131016 (2015).","journal-title":"Biochim. et. Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"682_CR38","doi-asserted-by":"publisher","first-page":"14554","DOI":"10.1021\/ja507832e","volume":"136","author":"HI Ing\u00f3lfsson","year":"2014","unstructured":"Ing\u00f3lfsson, H. I. et al. Lipid organization of the plasma membrane. J. Am. Chem. Soc. 136, 14554\u201314559 (2014).","journal-title":"J. Am. Chem. Soc."},{"key":"682_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","volume":"72","author":"Y Huang","year":"2014","unstructured":"Huang, Y. & Mahley, R. W. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases. Neurobiol. Dis. 72, 3\u201312 (2014).","journal-title":"Neurobiol. Dis."},{"key":"682_CR40","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch, C. M. & Goate, A. M. Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry 77, 43\u201351 (2015).","journal-title":"Biol. Psychiatry"},{"key":"682_CR41","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1002\/alz.12538","volume":"18","author":"T Wang","year":"2022","unstructured":"Wang, T. et al. APOE \u03b52 resilience for Alzheimer\u2019s disease is mediated by plasma lipid species: Analysis of three independent cohort studies. Alzheimers Dement 18, 2151\u20132166 (2022).","journal-title":"Alzheimers Dement"},{"key":"682_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2019.09.015","volume":"86","author":"BJ Neth","year":"2020","unstructured":"Neth, B. J. et al. Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer\u2019s disease: a pilot study. Neurobiol. aging 86, 54\u201363 (2020).","journal-title":"Neurobiol. aging"},{"key":"682_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7, 270\u2013279 (2011).","journal-title":"Alzheimers Dement"},{"key":"682_CR44","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jalz.2015.03.003","volume":"11","author":"SL Risacher","year":"2015","unstructured":"Risacher, S. L. et al. APOE effect on Alzheimer\u2019s disease biomarkers in older adults with significant memory concern. Alzheimer\u2019s. Dement. 11, 1417\u20131429 (2015).","journal-title":"Alzheimer\u2019s. Dement."},{"key":"682_CR45","doi-asserted-by":"crossref","unstructured":"Standards of Medical Care in Diabetes\u20142016 Abridged for Primary Care Providers. Clin Diabetes. 34:3\u201321 (2016).","DOI":"10.2337\/diaclin.34.1.3"},{"key":"682_CR46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/jn\/131.1.132","volume":"131","author":"RM Krauss","year":"2001","unstructured":"Krauss, R. M. et al. Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. J. Nutr. 131, 132\u2013146 (2001).","journal-title":"J. Nutr."},{"key":"682_CR47","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.chembiol.2018.10.008","volume":"26","author":"K Huynh","year":"2019","unstructured":"Huynh, K. et al. High-Throughput Plasma Lipidomics: Detailed Mapping of the Associations with Cardiometabolic Risk Factors. Cell Chem. Biol. 26, 71\u201384.e74 (2019).","journal-title":"Cell Chem. Biol."},{"key":"682_CR48","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00401-018-1851-x","volume":"136","author":"E Portelius","year":"2018","unstructured":"Portelius, E. et al. Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology. Acta Neuropathol. 136, 363\u2013376 (2018).","journal-title":"Acta Neuropathol."},{"key":"682_CR49","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000512","volume":"6","author":"M Gissl\u00e9n","year":"2019","unstructured":"Gissl\u00e9n, M. et al. CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection. Neurol. Neuroimmunol. Neuroinflamm 6, e512 (2019).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"key":"682_CR50","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/WAD.0b013e3181cfc78b","volume":"24","author":"E Grober","year":"2010","unstructured":"Grober, E., Sanders, A. E., Hall, C. & Lipton, R. B. Free and cued selective reminding identifies very mild dementia in primary care. Alzheimer Dis. Assoc. Disord. 24, 284\u2013290 (2010).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"682_CR51","unstructured":"Wechsler D. Wechsler Memory Scale-Revised. San Antonio, Texas: Psychological Corporation; 1987."},{"key":"682_CR52","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","volume":"141","author":"WG Rosen","year":"1984","unstructured":"Rosen, W. G., Mohs, R. C. & Davis, K. L. A new rating scale for Alzheimer\u2019s disease. Am. J. Psychiatry 141, 1356\u20131364 (1984).","journal-title":"Am. J. Psychiatry"},{"key":"682_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3102\/10769986025001060","volume":"25","author":"Y Benjamini","year":"2000","unstructured":"Benjamini, Y. & Hochberg, Y. On the Adaptive Control of the False Discovery Rate in Multiple Testing With Independent Statistics. J. Educ. Behav. Stat. 25, 60\u201383 (2000).","journal-title":"J. Educ. Behav. Stat."},{"key":"682_CR54","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/152165401753311780","volume":"51","author":"RL Veech","year":"2001","unstructured":"Veech, R. L., Chance, B., Kashiwaya, Y., Lardy, H. A. & Cahill, G. F. Jr. Ketone bodies, potential therapeutic uses. IUBMB Life 51, 241\u2013247 (2001).","journal-title":"IUBMB Life"},{"key":"682_CR55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0005-2760(91)90015-A","volume":"1081","author":"H Schulz","year":"1991","unstructured":"Schulz, H. Beta oxidation of fatty acids. Biochim. et. Biophys. Acta (BBA)-Lipids Lipid Metab. 1081, 109\u2013120 (1991).","journal-title":"Biochim. et. Biophys. Acta (BBA)-Lipids Lipid Metab."},{"key":"682_CR56","doi-asserted-by":"publisher","first-page":"30413","DOI":"10.1074\/jbc.R300017200","volume":"278","author":"L Reshef","year":"2003","unstructured":"Reshef, L. et al. Glyceroneogenesis and the triglyceride\/fatty acid cycle. J. Biol. Chem. 278, 30413\u201330416 (2003).","journal-title":"J. Biol. Chem."},{"key":"682_CR57","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1016\/S0021-9258(19)70821-7","volume":"237","author":"M Vaughan","year":"1962","unstructured":"Vaughan, M. The production and release of glycerol by adipose tissue incubated in vitro. J. Biol. Chem. 237, 3354\u20133358 (1962).","journal-title":"J. Biol. Chem."},{"key":"682_CR58","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s13238-017-0423-5","volume":"9","author":"JM Dean","year":"2018","unstructured":"Dean, J. M. & Lodhi, I. J. Structural and functional roles of ether lipids. Protein cell. 9, 196\u2013206 (2018).","journal-title":"Protein cell."},{"key":"682_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0009-3084(94)90054-X","volume":"74","author":"F Paltauf","year":"1994","unstructured":"Paltauf, F. Ether lipids in biomembranes. Chem. Phys. lipids 74, 101\u2013139 (1994).","journal-title":"Chem. Phys. lipids"},{"key":"682_CR60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0163-7827(01)00003-0","volume":"40","author":"N Nagan","year":"2001","unstructured":"Nagan, N. & Zoeller, R. A. Plasmalogens: biosynthesis and functions. Prog. lipid Res. 40, 199\u2013229 (2001).","journal-title":"Prog. lipid Res."},{"key":"682_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13610","volume":"232","author":"JT Hannich","year":"2021","unstructured":"Hannich, J. T. et al. Ether lipids, sphingolipids and toxic 1\u2010deoxyceramides as hallmarks for lean and obese type 2 diabetic patients. Acta Physiol. 232, e13610 (2021).","journal-title":"Acta Physiol."},{"key":"682_CR62","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12017-016-8423-9","volume":"19","author":"SM Hammad","year":"2017","unstructured":"Hammad, S. M. et al. Increased plasma levels of select deoxy-ceramide and ceramide species are associated with increased odds of diabetic neuropathy in type 1 diabetes: a pilot study. Neuromol. Med. 19, 46\u201356 (2017).","journal-title":"Neuromol. Med."},{"key":"682_CR63","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1021\/cr2002917","volume":"111","author":"AH Merrill Jr.","year":"2011","unstructured":"Merrill, A. H. Jr. Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics. Chem. Rev. 111, 6387\u20136422 (2011).","journal-title":"Chem. Rev."},{"key":"682_CR64","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","volume":"14","author":"SE Arnold","year":"2018","unstructured":"Arnold, S. E. et al. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat. Rev. Neurol. 14, 168\u2013181 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"682_CR65","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","volume":"9","author":"BJ Neth","year":"2017","unstructured":"Neth, B. J. & Craft, S. Insulin Resistance and Alzheimer\u2019s Disease: Bioenergetic Linkages. Front Aging Neurosci. 9, 345 (2017).","journal-title":"Front Aging Neurosci."},{"key":"682_CR66","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1073\/pnas.97.10.5440","volume":"97","author":"Y Kashiwaya","year":"2000","unstructured":"Kashiwaya, Y. et al. d-\u03b2-Hydroxybutyrate protects neurons in models of Alzheimer\u2019s and Parkinson\u2019s disease. Proc. Natl Acad. Sci. 97, 5440\u20135444 (2000).","journal-title":"Proc. Natl Acad. Sci."},{"key":"682_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.645646","volume":"12","author":"F Pifferi","year":"2021","unstructured":"Pifferi, F., Laurent, B. & Plourde, M. Lipid transport and metabolism at the blood-brain interface: Implications in health and disease. Front Physiol. 12, 645646 (2021).","journal-title":"Front Physiol."},{"key":"682_CR68","first-page":"200","volume":"9","author":"HM Dashti","year":"2004","unstructured":"Dashti, H. M. et al. Long-term effects of a ketogenic diet in obese patients. Exp. Clin. Cardiol. 9, 200\u2013205 (2004).","journal-title":"Exp. Clin. Cardiol."},{"key":"682_CR69","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11010-007-9448-z","volume":"302","author":"HM Dashti","year":"2007","unstructured":"Dashti, H. M. et al. Beneficial effects of ketogenic diet in obese diabetic subjects. Mol. Cell Biochem 302, 249\u2013256 (2007).","journal-title":"Mol. Cell Biochem"},{"key":"682_CR70","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11883-003-0038-6","volume":"5","author":"EC Westman","year":"2003","unstructured":"Westman, E. C., Mavropoulos, J., Yancy, W. S. & Volek, J. S. A review of low-carbohydrate ketogenic diets. Curr. Atherosclerosis Rep. 5, 476\u2013483 (2003).","journal-title":"Curr. Atherosclerosis Rep."},{"key":"682_CR71","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1139\/jpn.090059","volume":"35","author":"PL Wood","year":"2010","unstructured":"Wood, P. L. et al. Circulating plasmalogen levels and Alzheimer disease assessment scale\u2013cognitive scores in Alzheimer patients. J. Psychiatry Neurosci. 35, 59\u201362 (2010).","journal-title":"J. Psychiatry Neurosci."},{"key":"682_CR72","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1046\/j.1471-4159.2001.00332.x","volume":"77","author":"X Han","year":"2001","unstructured":"Han, X., Holtzman, D. M. & McKeel, Jr. D. W. Plasmalogen deficiency in early Alzheimer\u2019s disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J. Neurochem. 77, 1168\u20131180 (2001).","journal-title":"J. Neurochem."},{"key":"682_CR73","doi-asserted-by":"crossref","unstructured":"Gu J., et al. Plasmalogens eliminate aging-associated synaptic defects and microglia-mediated neuroinflammation in mice. Frontiers in Molecular Biosciences. 159 (2022).","DOI":"10.3389\/fmolb.2022.815320"},{"key":"682_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-019-1044-1","volume":"18","author":"XQ Su","year":"2019","unstructured":"Su, X. Q., Wang, J. & Sinclair, A. J. Plasmalogens and Alzheimer\u2019s disease: a review. Lipids health Dis. 18, 1\u201310 (2019).","journal-title":"Lipids health Dis."},{"key":"682_CR75","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.1073\/pnas.1917461117","volume":"117","author":"ER Werner","year":"2020","unstructured":"Werner, E. R. et al. The TMEM189 gene encodes plasmanylethanolamine desaturase which introduces the characteristic vinyl ether double bond into plasmalogens. Proc. Natl Acad. Sci. USA. 117, 7792\u20137798 (2020).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"682_CR76","doi-asserted-by":"crossref","unstructured":"Paul S., Lancaster G. I., Meikle P. J. JPilr. Plasmalogens: A potential therapeutic target for neurodegenerative and cardiometabolic disease. 74, 186\u2013195 (2019).","DOI":"10.1016\/j.plipres.2019.04.003"},{"key":"682_CR77","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0022-2275(20)31527-3","volume":"42","author":"S Ferdinandusse","year":"2001","unstructured":"Ferdinandusse, S. et al. Identification of the peroxisomal \u03b2-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. J. Lipid Res 42, 1987\u20131995 (2001).","journal-title":"J. Lipid Res"},{"key":"682_CR78","doi-asserted-by":"publisher","first-page":"E1053","DOI":"10.1152\/ajpendo.00410.2020","volume":"320","author":"TY Huang","year":"2021","unstructured":"Huang, T. Y. et al. Combined effects of a ketogenic diet and exercise training alter mitochondrial and peroxisomal substrate oxidative capacity in skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 320, E1053\u2013e1067 (2021).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"682_CR79","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1001\/archneurol.2009.27","volume":"66","author":"S Craft","year":"2009","unstructured":"Craft, S. The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia. Arch. Neurol. 66, 300\u2013305 (2009).","journal-title":"Arch. Neurol."},{"key":"682_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13578-019-0324-9","volume":"9","author":"A Ando","year":"2019","unstructured":"Ando, A., Oka, M. & Satomi, Y. Deoxysphingolipids and ether-linked diacylglycerols accumulate in the tissues of aged mice. Cell Biosci. 9, 1\u20137 (2019).","journal-title":"Cell Biosci."},{"key":"682_CR81","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3390\/nu13062118","volume":"13","author":"AM Dimache","year":"2021","unstructured":"Dimache, A. M., \u0218alaru, D. L., Sasc\u0103u, R. & St\u0103tescu, C. The role of high triglycerides level in predicting cognitive impairment: a review of current evidence. Nutrients 13, 2118 (2021).","journal-title":"Nutrients"},{"key":"682_CR82","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC201712050","volume":"167","author":"L Kopin","year":"2017","unstructured":"Kopin, L. & Lowenstein, C. J. Dyslipidemia. Ann. Intern. Med. 167, ITC81\u2013ITC96 (2017).","journal-title":"Ann. Intern. Med."},{"key":"682_CR83","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.ircmb.2015.10.001","volume":"321","author":"E Calzada","year":"2016","unstructured":"Calzada, E., Onguka, O. & Claypool, S. M. Phosphatidylethanolamine metabolism in health and disease. Int. Rev. cell Mol. Biol. 321, 29\u201388 (2016).","journal-title":"Int. Rev. cell Mol. Biol."},{"key":"682_CR84","doi-asserted-by":"crossref","unstructured":"Lacorte E., et al. Safety and efficacy of monoclonal antibodies for Alzheimer\u2019s disease: a systematic review and meta-analysis of published and unpublished clinical trials. J Alzheimers Dis. 87, 101\u2013129 (2022).","DOI":"10.3233\/JAD-220046"},{"key":"682_CR85","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu, T. et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 385, 2255\u20132263 (2015).","journal-title":"Lancet"},{"key":"682_CR86","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/WCO.0000000000000432","volume":"30","author":"D Boison","year":"2017","unstructured":"Boison, D. New insights into the mechanisms of the ketogenic diet. Curr. Opin. Neurol. 30, 187\u2013192 (2017).","journal-title":"Curr. Opin. Neurol."},{"key":"682_CR87","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073813487598","volume":"28","author":"NN Danial","year":"2013","unstructured":"Danial, N. N., Hartman, A. L., Stafstrom, C. E. & Thio, L. L. How does the ketogenic diet work? Four potential mechanisms. J. Child Neurol. 28, 1027\u20131033 (2013).","journal-title":"J. Child Neurol."},{"key":"682_CR88","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.brainresrev.2008.09.002","volume":"59","author":"M Maalouf","year":"2009","unstructured":"Maalouf, M., Rho, J. M. & Mattson, M. P. The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res Rev. 59, 293\u2013315 (2009).","journal-title":"Brain Res Rev."},{"key":"682_CR89","unstructured":"Masino, S. A. et al; (2012)."},{"key":"682_CR90","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/ejcn.2013.116","volume":"67","author":"A Paoli","year":"2013","unstructured":"Paoli, A., Rubini, A., Volek, J. S. & Grimaldi, K. A. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur. J. Clin. Nutr. 67, 789\u2013796 (2013).","journal-title":"Eur. J. Clin. Nutr."}],"updated-by":[{"DOI":"10.1038\/s43856-026-01571-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000}}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00682-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00682-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00682-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:02:49Z","timestamp":1775545369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-024-00682-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1038\/s43856-024-00682-w","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"25 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s43856-026-01571-0","URL":"https:\/\/doi.org\/10.1038\/s43856-026-01571-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Kaddurah-Daouk is an inventor on a series of patents on use of metabolomics for the diagnosis and treatment of CNS diseases and holds equity in Metabolon Inc., Chymia LLC and PsyProtix. JK holds equity in Chymia LLC and IP in PsyProtix and is cofounder of iollo. JK holds equity in Chymia LLC and IP in PsyProtix and is cofounder of iollo. Dr. Zetterberg has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). Rob Knight is a scientific advisory board member, and consultant for BiomeSense, Inc., has equity and receives income. He is a scientific advisory board member and has equity in GenCirq. He has equity in and acts as a consultant for Cybele. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}